<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To create a follow-up protocol for pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: We retrospectively reviewed the charts of patients who delivered in the Jeanne de Flandre University Hospital between June 1996 and June 1999 </plain></SENT>
<SENT sid="2" pm="."><plain>Four pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> were identified </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Three of these patients had Bentall procedure </plain></SENT>
<SENT sid="4" pm="."><plain>One of them had vaginal delivery and the two others underwent cesarean section </plain></SENT>
<SENT sid="5" pm="."><plain>One of these two patients developed aortic valve <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> at 14 weeks of <z:hpo ids='HP_0000141'>amenorrhea</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The fourth patient did not have surgery and had two vaginal deliveries </plain></SENT>
<SENT sid="7" pm="."><plain>DISCUSSION: According to our results and after reviewing literature pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> were divided into two groups </plain></SENT>
<SENT sid="8" pm="."><plain>The 1st group was comprised of patients who underwent Bentall procedure </plain></SENT>
<SENT sid="9" pm="."><plain>The 2nd one was comprised of patients who did not undergo any surgical procedure </plain></SENT>
<SENT sid="10" pm="."><plain>The possibility of vaginal delivery for patients who underwent Bentall procedure (one case) and the interest of <z:chebi fb="0" ids="8499">Propanolol</z:chebi> and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment are emphasized </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The multivariant approach of pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is stressed out with special reference to the potential complications of this syndrome such as <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> and to the problems related to the <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment </plain></SENT>
</text></document>